Pentosidine content in skin collagen from type II diabetic patients.
Contreras
I
I
Luis Razetti Medical School and University Hospital, Central University of Venezuela, Caracas.
Reiser
K M
KM
Martinez
N
N
Giansante
E
E
Lopez
T
T
Suarez
N
N
Postalian
S
S
Molina
M
M
Gonzalez-Mujica
F
F
Sanchez
M R
MR
D000328:Adult; D000704:Analysis of Variance; D001120:Arginine / Q000031:analogs & derivatives* / Q000032:analysis; D015415:Biomarkers / Q000032:analysis; D003094:Collagen / Q000737:chemistry*; D003432:Cross-Linking Reagents; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000378:metabolism*; D003929:Diabetic Neuropathies / Q000378:metabolism*; D004151:Dipeptides / Q000032:analysis; D006801:Humans; D008239:Lysine / Q000031:analogs & derivatives* / Q000032:analysis; D008875:Middle Aged; D012016:Reference Values; D012867:Skin / Q000737:chemistry* / Q000378:metabolism
D015415:Biomarkers; D003432:Cross-Linking Reagents; D004151:Dipeptides; C007428:5,5'-dihydroxylysylnorleucine; C010991:delta-hydroxylysylnorleucine; D003094:Collagen; D001120:Arginine; C062187:pentosidine; D008239:Lysine